Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
Cognizant has extended its partnership with Gilead Sciences for five years to support the biopharmaceutical…
Trending
- Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
- CSL, Alentis Partner on $1.55B Kidney and Liver Drug
- Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
- KymaThera Raises $80M to Advance PI3Kα Cancer Drug
- Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing
- AstraZeneca Opens $1B R&D Centre in Cambridge
- Pacira Partners With Molteni to Expand EXPAREL in Europe
- Shionogi Plans $2B Acquisition of IntraBio to Expand Rare Disease Portfolio
- Lilly’s Jaypirca Wins FDA Nod for First-Line CLL Treatment
- Lilly’s Foundayo Linked to Lower Long-Term Diabetes and Heart Disease Risk
Top Headlines
CSL, Alentis Partner on $1.55B Kidney and Liver Drug
CSL and Alentis Therapeutics have entered into an exclusive global collaboration to jointly develop and…
Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B
Alector has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, to…
KymaThera Raises $80M to Advance PI3Kα Cancer Drug
KymaThera has raised $80 million in a Series B financing to advance the development of its investigational cancer…
AstraZeneca Opens $1B R&D Centre in Cambridge
AstraZeneca has opened a new global research and development (R&D) centre in Kendall Square, Cambridge,…
Pacira Partners With Molteni to Expand EXPAREL in Europe
Pacira BioSciences has entered into a strategic partnership with Molteni Farmaceutici to expand access to…
Featured Event
Clinical Trials
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Boehringer Advances Phase III Cancer Precision Medicine Trials
Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the…
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with…
Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access
Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical…
Phase 3 Success Boosts Prospects for Iza-Bren
SystImmune and Bristol Myers Squibb have reported positive Phase 3 results for izalontamab brengitecan (iza-bren), an investigational bispecific…
GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment
British pharmaceutical company GSK has reported encouraging late-stage clinical trial results for bepirovirsen, an investigational therapy for chronic…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps
Cognizant has extended its partnership with Gilead Sciences for five years to support the biopharmaceutical…
AbbVie, Valkai Partner to Advance AI in Clinical Development
AbbVie has entered into a new collaboration with life sciences AI company Valkai to expand the use of artificial…
Drug Research
AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics to support the development of ivonescimab and…
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
Manufacturing
SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
SK pharmteco has announced a five-year investment of more than $200 million to expand and upgrade its development…
Varda Raises $251M to Scale Space-Based Pharmaceutical Manufacturing
Varda Space Industries has raised $251 million in a Series D financing round to expand its work in space-based…
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Fujifilm Expands Stem Cell Manufacturing in Wisconsin
FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development…
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
